期刊文献+

法舒地尔治疗老年慢性充血性心力衰竭临床疗效观察 被引量:3

Clinical effects of fasudil on chronic congestive heart failure in the elderly patients
原文传递
导出
摘要 目的观察法舒地尔治疗老年充血性心力衰竭的临床疗效。方法选取就诊于我院老年医学科充血性心力衰竭患者90例。根据随机分组原则分为对照组、治疗组。对照组患者使用常规抗心衰药物治疗;治疗组患者在对照组基础上联合法舒地尔60 mg静脉滴注,1次/d,2周为1个疗程,每月1个疗程,连续3月。观察2组患者治疗后临床症状、治疗总有效率、血清脑钠肽(BNP)、左室射血分数等指标变化。结果治疗组治疗总有效率为95.6%,显著高于对照组的82.2%(P<0.05);治疗后治疗组患者血清BNP、左室射血分数改善情况显著优于对照组(P<0.05)。结论使用法舒地尔治疗老年充血性心力衰竭能够有效改善心功能,且安全性高。 Objective To observe the clinical effects of fasudil on chronic congestive heart failure in the elderly patients. Methods Ninety elderly patients with chronic congestive heart failure were randomly divided into control group (45 cases)and treatment group (45 cases).The patients in control group received conventional anti-heart failure therapies and the patients in treatment group received fasudil based on the conventional therapies. The clinical symptoms, the total ef- fective rate, left ventricular ejection fraction (LVEF)and plasma brain natriuretic peptide (BNP) of the two groups were evaluated before and after three months' treatment. Results The total effective rate of the treatment group(95.6%) was significantly higher than that of the control group( 82. 2%)(P〈0. 05).The level of LVEF of the treatment group was better than that of the control group, while the level of BNP was significantly lower than that of the control group (P〈0. 05). Conclusions The routine treatment combined with fasudil therapy in the elderly patients with chronic congestive heart failure can improve the left ventricular functions.
出处 《实用老年医学》 CAS 2014年第7期577-579,共3页 Practical Geriatrics
关键词 老年人 充血性心力衰竭 法舒地尔 临床疗效 aged congestive heart failure fasudil clinical effect
  • 相关文献

参考文献8

  • 1张曼,屈晨,曾定尹.Rho/Rho激酶在压力负荷心力衰竭大鼠心肌组织的表达[J].中华心血管病杂志,2005,33(1):73-76. 被引量:52
  • 2Leung T, Manser E, Tan L, et al.A novel serine/threonine ki- nase binding the ras-related RhoA GTP ase which translocates the kinase to peripheral membranes [ J ]. J Biol Chem, 1995,270(49) :29051-29054.
  • 3Marzilli M, Klein WW. Efficacy and tolerability of trimetazidine instable angina., a meta-analysis of randomized, double-blind, controlled trials [ J ]. Coron Artery Dis ,2003,14(2) : 171-179.
  • 4王屹,潘梓青,丁林峰.快速脑钠素测定在慢性心力衰竭诊断中的应用[J].实用老年医学,2004,18(5):272-273. 被引量:7
  • 5Amano M, Ito M, Kimura K, et al.Phosphorylation and activa- tion of myosin by Rho-associated kinase (Rho-kinase) [ J ]. J Biol Chem, 1996,271 : 20246-20249.
  • 6Shimokawa H. Rho-kinase as a novel therapeutia target in treatment of cardiovascular diseases [ J ] .J Cardiovasc Phama- coi,2002,39(3) :319-327.
  • 7张新军,章茂顺.心肌炎症反应与心室重构[J].华西医学,2005,20(4):788-789. 被引量:6
  • 8Rikitake Y, Kim HH, Huang Z, et al.Inhibition of Rho linase (ROCK) leads to increased cerebral blood flow and stroke protection[J] .Stroke,2005,36(10) :2251-2257.

二级参考文献27

  • 1Hisaoka T, Yano M, Ohkusa T, et al. Enhancement of Rho/Rho kinase system in regulation of vascular smooth muscle contraction in tachycardia-induced heart failure. Cardiovasc Res, 2001,49: 319-329.
  • 2Suematsu N, Satoh S, Kinugawa S, et al. Alpha1-adrenoceptor-Gq-RhoA signaling is upregulated to increase myofibrillar Ca2+ sensitivity in failing hearts. Am J Physiol Heart Circ Physiol, 2001, 281: H637- H646.
  • 3Touyz RM, Fareh J, Thibault G, et al. Intracellular Ca^2+ modulation by angiotensin Ⅱ and endothelin-1 in cardiomyocytes and fibroblasts from hypertrophied hearts of spontaneously hypertensive rats. Hypertension, 1996, 28: 797-805.
  • 4Amano M, Ito M, Kimura K, et al. Phosphorylation and activation of myosin by Rho-associated kinase(Rho-kinase). J Biol Chem, 1996, 271: 20246-20249.
  • 5Solaro RJ. Myosin light chain phosphatase: a Cinderella of cellular signaling. J Circ Res, 2000, 87:173-175.
  • 6Shimokawa H. Rho-kinase as a novel therapeutic target in treatment of cardiovascular diseases. Cardiovasc Pharma,2002,39: 319-327.
  • 7Arai M, Matsui H, Periasamy M. Sarcoplasmic reticulum gene expression in cardiac hypertrophy and heart failure. J Circ Res, 1994, 74: 555-564.
  • 8Krishnaswamy P, Lubien E, Clopton P,et al. Utility of B-natriuretic peptide levels in identifying patients with left ventricular systolic or diastolic dysfunction [J].Am J Med,2001,111(4):274
  • 9Morrison LK,Harrison A,Krishnaswamy P,et al.Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea [J].J Am Coll Cardiol,2002,39(2):202
  • 10Dao Q, Krishnaswamy P,Kazanegra R, et al. Utility of B-type natriuretic peptide in the diagnosis of congestive heart fuilure in an urgent-care setting [J]. J Am Coll Cardiol,2001,37(2):379

共引文献59

同被引文献22

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部